Marisa Actis
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Protein Degradation and Inhibitors 6
- Ubiquitin and proteasome pathways 4
- Cell death mechanisms and regulation 1
- ATP Synthase and ATPases Research 1
- Mitochondrial Function and Pathology 1
- Oncology 3
- CAR-T cell therapy research 3
- Co-authors
- Zoran Ranković (7 shared papers)Shondra M. Pruett‐Miller (3 shared papers)Jamie Jarusiewicz (5 shared papers)Jaeki Min (4 shared papers)Shilpa Narina (3 shared papers)Gisele Nishiguchi (4 shared papers)Junmin Peng (2 shared papers)Lei Yang (4 shared papers)
- Journals
- ACS Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (1 paper)Science Translational Medicine (1 paper)ACS Chemical Biology (1 paper)Cell Death and Differentiation (1 paper)
- Partner nations
- United States
In The Last Decade
Marisa Actis
7 papers receiving 131 citations
Peers
Comparison fields: 5 of 40
- Hematology 40
- Oncology 44
- Molecular Biology 99
- Genetics 6
- Neurology 4
Countries citing papers authored by Marisa Actis
This map shows the geographic impact of Marisa Actis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Actis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Actis more than expected).
Fields of papers citing papers by Marisa Actis
This network shows the impact of papers produced by Marisa Actis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Actis. The network helps show where Marisa Actis may publish in the future.
Co-authors
The 25 scholars most cited alongside Marisa Actis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 44 | |
| 2 | 2022 | 38 | |
| 3 | 2022 | 24 | |
| 4 | 2022 | 22 | |
| 5 | 2023 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2021 | 1 |
About Marisa Actis
Marisa Actis is a scholar working on Molecular Biology, Oncology, Hematology, Pathology and Forensic Medicine and Neurology, having authored 7 papers that have together received 136 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (4 papers), CAR-T cell therapy research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Cell death mechanisms and regulation (1 paper), Lymphoma Diagnosis and Treatment (1 paper), ATP Synthase and ATPases Research (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Hematology (40 citations), Oncology (44 citations), Molecular Biology (99 citations), Genetics (6 citations) and Neurology (4 citations). Marisa Actis has collaborated with scholars based in United States. Frequent co-authors include Zoran Ranković, Shondra M. Pruett‐Miller, Jamie Jarusiewicz, Jaeki Min, Shilpa Narina, Gisele Nishiguchi, Junmin Peng, Lei Yang, Anand Mayasundari and Satoshi Yoshimura. Their work appears in journals such as ACS Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Science Translational Medicine, ACS Chemical Biology and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.